Product NDC: | 21695-867 |
Proprietary Name: | Mirapex |
Non Proprietary Name: | pramipexole dihydrochloride |
Active Ingredient(s): | .5 mg/1 & nbsp; pramipexole dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-867 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020667 |
Marketing Category: | NDA |
Start Marketing Date: | 20040101 |
Package NDC: | 21695-867-90 |
Package Description: | 90 TABLET in 1 BOTTLE (21695-867-90) |
NDC Code | 21695-867-90 |
Proprietary Name | Mirapex |
Package Description | 90 TABLET in 1 BOTTLE (21695-867-90) |
Product NDC | 21695-867 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pramipexole dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040101 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |